H.C. Wainwright reiterated coverage on ANI Pharma with a new price target

8/22/23 8:19:35 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

H.C. Wainwright reiterated coverage of ANI Pharma with a rating of Buy and set a new price target of $73.00 from $60.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ANIP

Date	Price Target	Rating	Analyst
3/14/2025	$80.00	Buy	Jefferies
3/12/2025	$85.00	Overweight	Analyst
12/11/2024	$80.00	Outperform	Leerink Partners
10/11/2024	$68.00	Overweight	Piper Sandler
3/15/2024	$80.00	Overweight	CapitalOne
8/22/2023	$60.00 → $73.00	Buy	H.C. Wainwright
3/1/2023	$55.00	Buy	Guggenheim
9/7/2022	$50.00	Buy	H.C. Wainwright